Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2011

[Federal Register Volume 76, Number 111 (Thursday, June 9, 2011)]
[Notices]
[Page 33785]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14253]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 28, 2011, Alltech Associates Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule
Methcathinone (1237)  I
N-ethylamphetamine (1475)  I
N,N-dimethylamphetamine (1480)  I
4-methylaminorex (cis isomer) (1590)  I
Alpha-ethyltryptamine (7249)  I
Lysergic acid diethylamide (7315)  I
2,5-dimethoxy-4-(n)- propylthiophenethylamine. (7348)  I
Tetrahydrocannabinols (7370)  I
Mescaline (7381)  I
4-bromo-2,5-dimethoxy-amphetamine (7391)  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)  I
4-methyl-2,5-dimethoxy-amphetamine (7395)  I
2,5-dimethoxyamphetamine (7396)  I
2,5-dimethoxy-4-ethylamphetamine (7399)  I
3,4-methylenedioxy amphetamine (7400)  I
N-hydroxy-3,4-methylenedioxyamphetamine (7402)  I
3,4-methylenedioxy-N-ethylamphetamine (7404)  I
3,4-methylenedioxymethamphetamine (MDMA) (7405)  I
4-methoxyamphetamine (7411)  I
Alpha-methyltryptamine (7432)  I
Bufotenine (7433)  I
Diethyltryptamine (7434)  I
Dimethyltryptamine (7435)  I
Psilocybin (7437)  I
Psilocyn (7438)  I
5-methoxy-N,N-diisopropyltryptamine (7439)  I
N-ethyl-1-phenylcyclohexylamine (7455)  I
1-(1-phenylcyclohexyl)-pyrrolidine (7458)  I
1-[1-(2-thienyl)-cyclohexyl]-piperidine (7470)  I
Dihydromorphine (9145)  I
Normorphine (9313)  I
Methamphetamine (1105)  II
1-phenylcyclohexylamine (7460)  II
Phencyclidine (7471)  II
Phenylacetone (8501)  II
1-piperidinocyclohexane-carbonitrile (8603)  II
Cocaine (9041)  II
Codeine (9050)  II
Dihydrocodeine (9120)  II
Ecgonine (9180)  II
Meperidine intermediate-B (9233)  II
Noroxymorphone (9668)  II

The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR Sec. 1301.33(a).

Any such comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than August 8, 2011.

Dated: June 1, 2011.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2011-14253 Filed 6-8-11; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility